Glenmede Trust’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $731K | Buy |
11,517
+485
| +4% | +$30.8K | ﹤0.01% | 790 |
|
|
2024
Q4 | $512K | Sell |
11,032
-19,219
| -64% | -$893K | ﹤0.01% | 925 |
|
|
2024
Q3 | $870K | Sell |
30,251
-4,565
| -13% | -$131K | ﹤0.01% | 757 |
|
|
2024
Q2 | $503K | Buy |
34,816
+370
| +1% | +$5.35K | ﹤0.01% | 903 |
|
|
2024
Q1 | $554K | Sell |
34,446
-475
| -1% | -$7.64K | ﹤0.01% | 900 |
|
|
2023
Q4 | $694K | Sell |
34,921
-4,084
| -10% | -$81.2K | ﹤0.01% | 802 |
|
|
2023
Q3 | $636K | Sell |
39,005
-5,475
| -12% | -$89.2K | ﹤0.01% | 771 |
|
|
2023
Q2 | $893K | Hold |
44,480
| – | – | 0.01% | 689 |
|
|
2023
Q1 | $893K | Buy |
44,480
+16,175
| +57% | +$325K | 0.01% | 691 |
|
|
2022
Q4 | $740K | Sell |
28,305
-1,910
| -6% | -$49.9K | ﹤0.01% | 724 |
|
|
2022
Q3 | $308K | Buy |
+30,215
| New | +$308K | ﹤0.01% | 949 |
|